Adam A. Carr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Abstract: Disclosed are compositions and methods for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count. The methods and compositions described herein include a fusion polypeptide formed from human serum albumin protein (“HSA”) and human granulocyte-colony stimulating factor (“G-CSF”).
December 18, 2014
July 23, 2015
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Jason Benjamin BOCK, Adam Carr BELL, Jeffery HERPST